| Similar Articles |
|---|
 |
Bio-IT World
April 2006
Samara McCarthy |
Ireland's Biotech Boom How the Emerald Isle has made its name in the life sciences.   |
Pharmaceutical Executive
June 1, 2013 |
Country Report: Ireland Ireland has been a pharma industry darling since the 1960s, when a then-newly established IDA targeted the sector as a strategic area for development. Today, the numbers are eye catching. |
Chemistry World
November 22, 2010
Akshat Rathi |
Irish drug industry fears bailout tax terms Any increase in Ireland's corporation tax rate as part of a financial bailout could hurt the country's rapidly expanding pharmaceutical industry, currently its largest contributor to corporation tax. |
Chemistry World
September 12, 2011
Andrew Turley |
Ireland Still Attractive to Pharma Industry The drug industry is still keen to invest in Ireland. |
BusinessWeek
September 27, 2004 |
Eminent Minds on the Emerald Isle The Irish proved they aren't afraid to go across the Atlantic when they hired William C. Harris, a 19-year veteran of the U.S. National Science Foundation, to head the government's fledgling Science Foundation Ireland in 2001. |
CFO
June 1, 2011
Janet Kersnar |
Back on the Map Ireland's domestic economy may be in shambles, but expansion-minded U.S. firms see plenty of opportunity there. |
Chemistry World
August 7, 2012
Anthony King |
Irish pharma exports tumble Irish pharma exports to the US declined 30% in the first six months of this year as a clatter of blockbuster drugs made in Ireland, such as Lipitor (atorvastatin), came off patent. |
BusinessWeek
November 24, 2010
Heatley & Gotkine |
Battered Ireland Clings to Its Low Taxes Though Ireland needs $115 billion, it says its 12.5 percent corporate tax rate is "non-negotiable" |
InternetNews
July 1, 2004
Colin C. Haley |
Lucent Extends R&D Roots The company's Bell Labs partners with Irish government on research center in Dublin. |
Pharmaceutical Executive
September 1, 2014
William Looney |
Ireland's Celtic Tiger: Back on the Hunt Leaders from industry, government, and the CRO community examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the leading exporter of finished pharmaceutical products. |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape. |
BusinessWeek
June 11, 2009
Kerry Capell |
Novartis: Radically Remaking Its Drug Business CEO Dan Vasella's growth mantra for Novartis is follow the science, not the financials. |
BusinessWeek
October 14, 2010
Fahy & Flynn |
Ireland's Unemployed Head Back to the Farm Ireland has a 13.8 percent jobless rate, but the food sector is thriving. |
BusinessWeek
November 17, 2003
Kerry Capell |
Nurturing Homegrown Talent In Ireland Ireland's economic boom was built largely on the back of multinationals, a fact that is becoming troublesome. In response, the Irish government is shifting gears. To continue attracting foreign investment, officials realize they must also foster homegrown talent. |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector |
InternetNews
October 16, 2009 |
IBM Ramps Up Analytics Research Abroad IBM teams up with Ireland's IDA to develop advanced risk analytics technologies. |
The Motley Fool
November 30, 2011
Isaac Pino |
I Was Wrong About Ireland The Celtic Tiger economy exited as quickly as it arrived on the Emerald Isle. |
Pharmaceutical Executive
September 1, 2008 |
How Do You Solve a Problem Like Manufacturing? Outsourcing saves pharmaceutical companies money -- except when it doesn't. Here's how to decide what to do. |
The Motley Fool
February 26, 2010
Brian Orelli |
Drug Company Cost Cuts: Careful What You Wish For Research and development is the lifeblood of future revenue. |
The Motley Fool
November 6, 2006
Brian Gorman |
Novartis' China Gambit Novartis probably won't get any near-term dividend from its China investment, but the nation is too big to ignore. Investors, take note. |
The Motley Fool
May 12, 2005
Stephen D. Simpson |
Should You Bank on Ireland? Bank of Ireland is doing fine, but it may not be the best stock pick on the Emerald Isle. |
InternetNews
May 19, 2004
Sean Michael Kerner |
Intel Invests $2B in 65-Nano The company builds out its Fab 24 in Ireland to keep its cutting edge in the sub-90 nanometer race. |
Chemistry World
December 11, 2015
Anthony King |
All boats to be lifted by Irish science strategy A new science strategy crafted by the Irish government is promising to boost national research funding to 2.5% of GNP, up from 1.8%, by 2020. |
Fast Company
February 2009
Elizabeth Svoboda |
Wyeth's Multibillion-dollar Biotech Bet Drugmaker Wyeth bet billions on biotech, transforming its culture and boosting profits. |
The Motley Fool
April 5, 2011
Zeeshan Siddique |
Can Bank of Ireland Dodge This Bullet Yet Again? After failing a stress test, Bank of Ireland struggles retaining its independence. |
BusinessWeek
October 18, 2004
Catherine Arnst |
The Waning of the Blockbuster Drug What's promising now are drugs that target niche diseases. That means painful restructuring ahead for Big Pharma |
The Motley Fool
May 7, 2010
Brian Orelli |
Drug Companies: Recession-Resistant, but Government-Proof? Greece decided to take action and forced drugmakers to reduce drug costs by an average of 21.5%. Investors need to think twice before making the seemingly sure bet on pharmaceutical companies. |
Chemistry World
March 14, 2014
Phillip Broadwith |
Bristol-Myers Squibb to close Irish plant BMS tied the closure to 'changing market demand' for its products, along with efforts to optimize its manufacturing network. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Southwest Region Texas: Bioscience with a Space Spin... New Mexico: Building a Bioinformatics Niche... Arizona: Focus on Cancer and Neurological Therapy... Southern California: Deep Biotech Roots Grow Many Branches... Northern California: 'Can You Afford To Be Elsewhere?'... |
BusinessWeek
July 26, 2004
Kerry Capell |
Ireland: A Nation Of Immigrants? Foreigners are flocking to Ireland's jobs and schools -- but the welcome may cool. |
The Motley Fool
September 7, 2010
Gerard Torres |
Sovereign Debt Crisis Continued: Irish Banks The downgrade of Ireland's credit rating has a large impact on Irish banks. |
Bio-IT World
June 15, 2003
Bob Violino |
Northeast Region Massachusetts: University and Research Hub... Connecticut: Investing in Bio Facilities... New York: Biotech Empire State... New Jersey: Still Big Pharma Country... Pennsylvania: Life Sciences, a Keystone Industry |
Bank Technology News
January 2002
Louise West |
Irish Innovation Woos Global Banks From voice verification to secure online payments, innovative and fast moving Irish financial software companies are scoring successes with international banks, despite the global economic downturn. |
The Motley Fool
January 31, 2011
Brian Orelli |
Pharma Goes Back to School But will it produce more drugs? The pharmaceutical industry is headed back to school, with a number of large drugmakers announcing partnerships with universities. |
The Motley Fool
August 17, 2010
Travers & Jayson |
Is Alexion Pharmaceuticals Burning Out? The first step toward finding a promising biotech company is not to figure out whether the science is any good, but to make sure that the company is financially healthy. |
IndustryWeek
November 1, 2008
David Blanchard |
IBM Unveils Global Supply Chain Hub in Ireland New IBM facility was designed with green strategies in mind. |
Bank Systems & Technology
February 27, 2009
Orla O'Sullivan |
Millions Walk From Irish Bank Amid Shoddy Security Public outcry in Ireland that an estimated 7 million Euro was stolen from the country's biggest bank because of poor procedures. |
The Motley Fool
August 17, 2010
Travers & Jayson |
How Long Can Amylin Pharmaceuticals Last? You don't need an advanced degree in pharmacology to find biotech companies with a legitimate chance of hitting it big. |
CFO
December 1, 2006
Kate O'Sullivan |
Biotech Dreaming Cities and states in the U.S. are vying to become biotechnology hot spots. Ultimately, some regions may not have enough of the key ingredients for biotech success. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Northwest Region Colorado: Biotech Summit in Denver... Utah: A Mecca for Genealogical Research... Washington State: Therapeutics and Diagnostics Niche... |
The Motley Fool
August 17, 2010
Travers & Jayson |
Interested in Cephalon ? Start Here! Every biotech company wants to discover the cure for cancer, Alzheimer's, or Wii knee. Every biotech investor hopes to catch the next Valeant Pharmaceuticals. |
On Wall Street
February 1, 2011
Milton Ezrati |
Europe's Debt Crisis Continues, Despite Ireland's Resolved Debt No one will find a way to rest easy about european finances for a long time to come. |
The Motley Fool
November 4, 2011
Matt Koppenheffer |
Ireland Continues Turning the Screws ... on Itself Ireland is planning $17 billion of additional austerity measures over the next four years as the country continues to grapple with a heavy debt load and a slowing economy. |
The Motley Fool
April 13, 2011
Jordan DiPietro |
Ireland's Race Toward Catastrophe Things keep worsening for the Emerald Isle's banks. |
Bio-IT World
May 19, 2004
Barbara Depompa |
Turning Sugar into Science The landmark building that housed the New England Confectionery Company in Revere, Mass. is being transformed into the new headquarters for the Novartis Institutes for BioMedical Research. |
The Motley Fool
June 7, 2007
Brian Lawler |
Are You Ignoring the Most Exciting Stocks? Never considered drug stocks? You're missing some of the market's best investments. |
BusinessWeek
February 11, 2010
Kerry Capell |
The New Generation Leaving Ireland Some 170,000 jobs vanished last year, and the lack of employment is driving a generation away. |
Reason
February 2003
Michael Valdez Moses |
Wherever Green Is Worn? Multiculturalism in contemporary Ireland: a review of Multi-culturalism: The View from the Two Irelands, a brief book featuring essays by two of the island's most prominent literary critics: Edna Longley (who resides in Northern Ireland) and Declan Kiberd (who lives in the Republic). |
The Motley Fool
April 18, 2011
Zeeshan Siddique |
What Can We Learn From Bank of Ireland's Shrinking Loss? Bank of Ireland betters its performance. But is it good enough? |
InternetNews
March 2, 2005
Clint Boulton |
HP Buys Into Irish Business Continuity The acquisition of Schlumberger Business Continuity Services gives HP Ireland a bigger presence in services that help make sure enterprises stay up and running in the event of a natural or man-made disaster. |
